International Journal of Infectious Diseases
Volume 14, Issue 9 , Pages e770-e774 , September 2010

Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines

  • P.H.A. Bours

      Affiliations

    • Department of Internal Medicine and Infectious Diseases, University Medical Center, PO Box 85500, Room F.02.126, 3508 GA Utrecht, the Netherlands
    • P.H.A. Bours and R. Polak contributed equally to this work.
    • Corresponding Author InformationCorresponding author. Tel.: +31 338501281.
    • ,
  • R. Polak

      Affiliations

    • Department of Internal Medicine and Infectious Diseases, University Medical Center, PO Box 85500, Room F.02.126, 3508 GA Utrecht, the Netherlands
    • P.H.A. Bours and R. Polak contributed equally to this work.
    • ,
  • A.I.M. Hoepelman

      Affiliations

    • Department of Internal Medicine and Infectious Diseases, University Medical Center, PO Box 85500, Room F.02.126, 3508 GA Utrecht, the Netherlands
    • ,
  • E. Delgado

      Affiliations

    • Department of Medicine, University Hospital, Universidad Nacional Autónoma de Nicaragua (UNAN), León, Nicaragua
    • ,
  • A. Jarquin

      Affiliations

    • Department of Medicine, University Hospital, Universidad Nacional Autónoma de Nicaragua (UNAN), León, Nicaragua
    • ,
  • A.J. Matute

      Affiliations

    • Department of Medicine, University Hospital, Universidad Nacional Autónoma de Nicaragua (UNAN), León, Nicaragua

Received 3 October 2009 ,Accepted 25 February 2010.

References 

  1. Matute AJ, Hak E, Schurink CA, McArthur A, Alonso E, Paniagua M, et al. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Int J Antimicrob Agents. 2004;23:506–509
  2. Gales AS, Sader HS, Jones RN SENTRY Participants Group (Latin America). Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997–2000). Diagn Microbiol Infect Dis. 2002;44:289–299
  3. Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari AC, Gales AC. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?. Mem Inst Oswaldo Cruz. 2006;101:741–748
  4. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29:745–758
  5. Bean D, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Ann Clin Microbiol Antimicrob. 2008;7:13
  6. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob. 2007;6:4
  7. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33:89–94
  8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl):5S–13S
  9. Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–515
  10. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15(Suppl 1):S216–S227
  11. Rubenstein JN, Schaeffer AJ. Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am. 2003;17:333–351
  12. European Confederation of Laboratory Medicine. European urinalysis guidelines: summary. Scand J Clin Lab Invest 2000; 60:1–96.
  13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th informational supplement. M100-S18. Wayne, PA: CLSI; 2008.
  14. Su LH, Ou JT, Leu HS, Chiang PC, Chiu YP, Chia JH, et al. Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. J Clin Microbiol. 2003;41:4726–4732
  15. Kim BN, Choi SI, Ryoo NH. Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit. J Korean Med Sci. 2006;21:973–978
  16. Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP, et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis. 2004;49:217–222
  17. Savini V, Catavitello C, Talia M, Manna A, Pompetti F, Favaro M, et al. Multidrug-resistant Escherichia fergusonii: a case of acute cystitis. J Clin Microbiol. 2008;46:1551–1552
  18. Mahapatra A, Mahapatra S, Mahapatra A. Escherichia fergusonii: an emerging pathogen in South Orissa. Indian J Med Microbiol. 2005;23:204
  19. Rossi F, García P, Ronzon B, Curcio D, Dowzicky MJ. Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis. 2008;12:405–415
  20. Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc. 2004;79:1048–1054
  21. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis. 2004;39:74–80
  22. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of uncomplicated cystitis in women. Arch Intern Med. 2007;167:2207–2212
  23. Kashanian J, Hakimiam P, Blute M, Wong J, Khanna H, Wise G, et al. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int. 2008;102:1634–1637
  24. Hooton TM. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents. 2003;22(Suppl 2):S65–72
  25. Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract. 2002;52:752–761
  26. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. EAU guidelines for the management of urinary and male genital tract infections. Eur Urol. 2001;40:576–588
  27. Nickel JC. Management of urinary tract infections: historical perspective and current strategies: part 2—modern management. J Urol. 2005;173:27–32

PII: S1201-9712(10)02399-4

doi: 10.1016/j.ijid.2010.02.2264

International Journal of Infectious Diseases
Volume 14, Issue 9 , Pages e770-e774 , September 2010

Article Tools